M. Ozkan Et Al. , "Low molecular weight heparin (LMWH) treatment in cancer patients with low risk venous thromboembolism - results of Turkish Observational Study (TREBECA)," European Cancer Congress , vol.51, Vienna, Austria, 2015
Ozkan, M. Et Al. 2015. Low molecular weight heparin (LMWH) treatment in cancer patients with low risk venous thromboembolism - results of Turkish Observational Study (TREBECA). European Cancer Congress , (Vienna, Austria).
Ozkan, M., Cicin, I., Ozaslan, E., Benekli, M., Oksuzoglu, B., Kocer, M., ... Isikdogan, A.(2015). Low molecular weight heparin (LMWH) treatment in cancer patients with low risk venous thromboembolism - results of Turkish Observational Study (TREBECA) . European Cancer Congress, Vienna, Austria
Ozkan, M. Et Al. "Low molecular weight heparin (LMWH) treatment in cancer patients with low risk venous thromboembolism - results of Turkish Observational Study (TREBECA)," European Cancer Congress, Vienna, Austria, 2015
Ozkan, M. Et Al. "Low molecular weight heparin (LMWH) treatment in cancer patients with low risk venous thromboembolism - results of Turkish Observational Study (TREBECA)." European Cancer Congress , Vienna, Austria, 2015
Ozkan, M. Et Al. (2015) . "Low molecular weight heparin (LMWH) treatment in cancer patients with low risk venous thromboembolism - results of Turkish Observational Study (TREBECA)." European Cancer Congress , Vienna, Austria.
@conferencepaper{conferencepaper, author={M. Ozkan Et Al. }, title={Low molecular weight heparin (LMWH) treatment in cancer patients with low risk venous thromboembolism - results of Turkish Observational Study (TREBECA)}, congress name={European Cancer Congress}, city={Vienna}, country={Austria}, year={2015}}